Mitochondrial nuclear receptors and transcription factors: Who's minding the cell?

Journal of Neuroscience Research

Volumn 86, Issue 5, 2008, Pages 961-971

  Lee, Junghee ^a,b   Sharma, Swati ^a,b   Kim, Jinho ^a,b   Ferrante, Robert J ^a   Ryu, Hoon ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Mitochondria; Neurodegeneration; Transcription regulation

Indexed keywords

ADENOSINE TRIPHOSPHATE; CELL NUCLEUS RECEPTOR; CYCLIC AMP; CYCLIC AMP BINDING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; ESTROGEN RECEPTOR; KT 5720; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PROTEIN P53; SELECTIVE ESTROGEN RECEPTOR MODULATOR; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR;

CELL ACTIVITY; CELL DEATH; CELL FUNCTION; CELL ORGANELLE; CELL SURVIVAL; DEGENERATIVE DISEASE; MITOCHONDRION; NERVE CELL NECROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL NUCLEUS; ENERGY METABOLISM; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 41149153932     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21564     Document Type: Review

References (98)

1. Albers DS, Beal MF. 2000. Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J Neural Transm Suppl 59:133-154.
2. Bae BI, Xu H, Igarashi S, Fujimuro M, Agrawal N, Taya Y, Hayward SD, Moran TH, Montell C, Ross CA, Snyder SH, Sawa A. 2005. p53 Mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron 47:29-41.
3. Beal MF, Hyman BT, Koroshetz W. 1993. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci 16:125-131.
4. Bevilaqua LR, Cammarota M, Paratcha G, de Stein ML, Izquierdo I, Medina JH. 1999. Experience-dependent increase in cAMP-responsive element binding protein in synaptic and nonsynaptic mitochondria of the rat hippocampus. Eur J Neurosci 11:3753-3756.
5. Bogdanov MB, Ferrante RJ, Kuemmerle S, Klivenyi P, Beal MF. 1998. Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington's disease. J Neurochem 71:2642-2644.
6. Bohnert M, Pfanner N, van der Laan M. 2007. A dynamic machinery for import of mitochondrial precursor proteins. FEBS Lett 581:2802-2810.
7. Caelles C, Helmberg A, Karin M. 1994. p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370:220-223.
8. Cammarota M, Paratcha G, Bevilaqua LR, Levi de Stein M, Lopez M, Pellegrino de Iraldi A, Izquierdo I, Medina JH. 1999. Cyclic AMP-responsive element binding protein in brain mitochondria. J Neurochem 72:2272-2277.
9. Casas F, Domenjoud L, Rochard P, Hatier R, Rodier A, Daury L, Bianchi A, Kremarik-Bouillaud P, Becuwe P, Keller J, Schohn H, Wrutniak-Cabello C, Cabello G, Dauca M. 2000. A 45 kDa protein related to PPARgamma2, induced by peroxisome proliferators, is located in the mitochondrial matrix. FEBS Lett 478:4-8.
10. Chen JQ, Yager JD. 2004. Estrogen's effects on mitochondrial gene expression: mechanisms and potential contributions to estrogen carcinogenesis. Ann N Y Acad Sci 1028:258-272.
11. Chen JQ, Delannoy M, Cooke C, Yager JD. 2004a. Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells. Am J Physiol Endocrinol Metab 286:E1011-E1022.
12. Chen JQ, Eshete M, Alworth WL, Yager JD. 2004b. Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors alpha and beta to human mitochondrial DNA estrogen response elements. J Cell Biochem 93:358-373.
13. Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR. 2005. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309:1732-1735.
14. Clayton DA. 1982. Replication of animal mitochondrial DNA. Cell 28:693-705.
15. Clayton DA. 1987. Nuclear gene products that function in mitochondrial DNA replication. Philos Trans R Soc Lond B Biol Sci 317:473-482.
16. Cogswell PC, Kashatus DF, Keifer JA, Guttridge DC, Reuther JY, Bristow C, Roy S, Nicholson DW, Baldwin AS Jr. 2003. NF-kappa B and I kappa B alpha are found in the mitochondria. Evidence for regulation of mitochondrial gene expression by NF-kappa B. J Biol Chem 278:2963-2968.
17. Dairaghi DJ, Shadel GS, Clayton DA. 1995. Human mitochondrial transcription factor A and promoter spacing integrity are required for transcription initiation. Biochim Biophys Acta 1271:127-134.
18. Demonacos CV, Karayanni N, Hatzoglou E, Tsiriyiotis C, Spandidos DA, Sekeris CE. 1996. Mitochondrial genes as sites of primary action of steroid hormones. Steroids 61:226-232.
19. Diffley JF, Stillman B. 1991. A close relative of the nuclear, chromosomal high-mobility group protein HMG1 in yeast mitochondria. Proc Natl Acad Sci U S A 88:7864-7868.
20. Dribben W, Nemmers B, Nardi A, Taylor G, Olney J, Farber N. 2003. Chronic but not acute estradiol treatment protects against the neurodegenerative effects of N-methyl-D-aspartate receptor antagonists. Endocrine 21:53-58.
21. Falkenberg M, Gaspari M, Rantanen A, Trifunovic A, Larsson NG, Gustafsson CM. 2002. Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA. Nat Genet 31:289-294.
22. Farhat MY, Abi-Younes S, Ramwell PW. 1996. Non-genomic effects of estrogen and the vessel wall. Biochem Pharmacol 51:571-576.
23. Fernandez-Silva P, Martinez-Azorin F, Micol V, Attardi G. 1997. The human mitochondrial transcription termination factor (mTERF) is a multizipper protein but binds to DNA as a monomer, with evidence pointing to intramolecular leucine zipper interactions. EMBO J 16:1066-1079.
24. Fernandez-Silva P, Enriquez JA, Montoya J. 2003. Replication and transcription of mammalian mitochondrial DNA. Exp Physiol 88:41-56.
25. Ferrante RJ, Andreassen OA, Dedeoglu A, Ferrante KL, Jenkins BG, Hersch SM, Beal MF. 2002. Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease. J Neurosci 22:1592-1599.
26. Garesse R, Vallejo CG. 2001. Animal mitochondrial biogenesis and function: a regulatory cross-talk between two genomes. Gene 263:1-16.
27. Green PS, Gordon K, Simpkins JW. 1997. Phenolic A ring requirement for the neuroprotective effects of steroids. J Steroid Biochem Mol Biol 63:229-235.
28. Halaby MJ, Yang DQ. 2007. p53 Translational control: a new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics. Gene 395:1-7.
29. Hansson O, Petersen A, Leist M, Nicotera P, Castilho RF, Brundin P. 1999. Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc Natl Acad Sci U S A 96:8727-8732.
30. Hansson O, Castilho RF, Korhonen L, Lindholm D, Bates GP, Brundin P. 2001. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length. J Neurochem 78:694-703.
31. Haupt Y, Rowan S, Shaulian E, Vousden KH, Oren M. 1995. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev 9:2170-2183.
32. Hazel TG, Nathans D, Lau LF. 1988. A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily. Proc Natl Acad Sci U S A 85:8444-8448.
33. Hood DA, Joseph AM. 2004. Mitochondrial assembly: protein import. Proc Nutr Soc 63:293-300.
34. Ioannou IM, Tsawdaroglou N, Sekeris CE. 1988. Presence of glucocorticoid responsive elements in the mitochondrial genome. Anticancer Res 8:1405-1409.
35. Jean D, Harbison M, McConkey DJ, Ronai Z, Bar-Eli M. 1998. CREB and its associated proteins act as survival factors for human melanoma cells. J Biol Chem 273:24884-24890.
36. Jeong JH, Park JS, Moon B, Kim MC, Kim JK, Lee S, Suh H, Kim ND, Kim JM, Park YC, Yoo YH. 2003. Orphan nuclear receptor Nur77 translocates to mitochondria in the early phase of apoptosis induced by synthetic chenodeoxycholic acid derivatives in human stomach cancer cell line SNU-1. Ann N Y Acad Sci 1010:171-177.
37. Kajta M, Lason W, Bien E, Marszal M. 2002. Neuroprotective effects of estrone on NMDA-induced toxicity in primary cultures of rat cortical neurons are independent of estrogen receptors. Pol J Pharmacol 54:727-729.
38. Ke N, Claassen G, Yu DH, Albers A, Fan W, Tan P, Grifman M, Hu X, Defife K, Nguy V, Meyhack B, Brachat A, Wong-Staal F, Li QX. 2004. Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis. Cancer Res 64:8208-8212.
39. Larsson NG, Wang J, Wilhelmsson H, Oldfors A, Rustin P, Lewandoski M, Barsh GS, Clayton DA. 1998. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet 18:231-236.
40. Lee J, Kim CH, Simon DK, Aminova LR, Andreyev AY, Kushnareva YE, Murphy AN, Lonze BE, Kim KS, Ginty DD, Ferrante RJ, Ryu H, Ratan RR. 2005. Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival. J Biol Chem 280:40398-40401.
41. Lee WK, Thevenod F. 2006. A role for mitochondrial aquaporins in cellular life-and-death decisions? Am J Physiol Cell Physiol 291:C195-C202.
42. Leist M, Nicotera P. 1998. Apoptosis vs. necrosis: the shape of neuronal cell death. Results Probl Cell Differ 24:105-135.
43. Leong H, Riby JE, Firestone GL, Bjeldanes LF. 2004. Potent ligand-independent estrogen receptor activation by 3,3′-diindolylmethane is mediated by cross talk between the protein kinase A and mitogen-activated protein kinase signaling pathways. Mol Endocrinol 18:291-302.
44. Li H, Kolluri SK, Gu J, Dawson MI, Cao X, Hobbs PD, Lin B, Chen G, Lu J, Lin F, Xie Z, Fontana JA, Reed JC, Zhang X. 2000. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 289:1159-1164.
45. Lin B, Kolluri SK, Lin F, Liu W, Han YH, Cao X, Dawson MI, Reed JC, Zhang XK. 2004. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116:527-540.
46. Linford NJ, Dorsa DM. 2002. 17Beta-estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin. Steroids 67:1029-1040.
47. Liu ZG, Smith SW, McLaughlin KA, Schwartz LM, Osborne BA. 1994. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature 367:281-284.
48. Lonze BE, Ginty DD. 2002. Function and regulation of CREB family transcription factors in the nervous system. Neuron 35:605-623.
49. Mahyar-Roemer M, Fritzsche C, Wagner S, Laue M, Roemer K. 2004. Mitochondrial p53 levels parallel total p53 levels independent of stress response in human colorectal carcinoma and glioblastoma cells. Oncogene 23:6226-6236.
50. Marchenko ND, Zaika A, Moll UM. 2000. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 275:16202-16212.
51. Mayr B, Montminy M. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2:599-609.
52. Mendez P, Azcoitia I, Garcia-Segura LM. 2003. Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain. Brain Res Mol Brain Res 112:170-176.
53. Meyer TE, Habener JF. 1993. Cyclic adenosine 3′,5′- monophosphate response element binding protein (CREB) and related transcriptionactivating deoxyribonucleic acid-binding proteins. Endocr Rev 14:269-290.
54. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, Moll UM. 2003. p53 Has a direct apoptogenic role at the mitochondria. Mol Cell 11:577-590.
55. Moll UM, Marchenko N, Zhang XK. 2006. p53 And Nur77/TR3-transcription factors that directly target mitochondria for cell death induction. Oncogene 25:4725-4743.
56. Montal M. 1998. Mitochondria, glutamate neurotoxicity and the death cascade. Biochim Biophys Acta 1366:113-126.
57. Montoya J, Gaines GL, Attardi G. 1983. The pattern of transcription of the human mitochondrial rRNA genes reveals two overlapping transcription units. Cell 34:151-159.
58. Mukhopadhyay A, Ni L, Weiner H. 2004. A co-translational model to explain the in vivo import of proteins into HeLa cell mitochondria. Biochem J 382:385-392.
59. Murashov AK, Islamov RR, McMurray RJ, Pak ES, Weidner DA. 2004. Estrogen increases retrograde labeling of motoneurons: evidence of a nongenomic mechanism. Am J Physiol Cell Physiol 287:C320-C326.
60. Murphy MP. 1997. Selective targeting of bioactive compounds to mitochondria. Trends Biotechnol 15:326-330.
61. Murphy MP, Smith RA. 2000. Drug delivery to mitochondria: the key to mitochondrial medicine. Adv Drug Deliv Rev 41:235-250.
62. Neupert W. 1997. Protein import into mitochondria. Annu Rev Biochem 66:863-917.
63. Neupert W, Herrmann JM. 2007. Translocation of proteins into mitochondria. Annu Rev Biochem 76:723-749.
64. Ni L, Heard TS, Weiner H. 1999. In vivo mitochondrial import. A comparison of leader sequence charge and structural relationships with the in vitro model resulting in evidence for co-translational import. J Biol Chem 274:12685-12691.
65. Nicholls DG, Ferguson SJ. 1992. Bioenergetics 2. London: Academic Press.
66. Nicotera P, Leist M, Ferrando-May E. 1998. Intracellular ATP, a switch in the decision between apoptosis and necrosis. Toxicol Lett 102-103:139-142.
67. Ogita K, Okuda H, Kitano M, Fujinami Y, Ozaki K, Yoneda Y. 2002. Localization of activator protein-1 complex with DNA binding activity in mitochondria of murine brain after in vivo treatment with kainate. J Neurosci 22:2561-2570.
68. Ogita K, Fujinami Y, Kitano M, Yoneda Y. 2003. Transcription factor activator protein-1 expressed by kainate treatment can bind to the noncoding region of mitochondrial genome in murine hippocampus. J Neurosci Res 73:794-802.
69. Ojala D, Montoya J, Artardi G. 1981. tRNA punctuation model of RNA processing in human mitochondria. Nature 290:470-474.
70. Parisi MA, Clayton DA. 1991. Similarity of human mitochondrial transcription factor 1 to high mobility group proteins. Science 252:965-969.
71. Rossmanith W, Tullo A, Potuschak T, Karwan R, Sbisa E. 1995. Human mitochondrial tRNA processing. J Biol Chem 270:12885-12891.
72. Ryu H, Lee J, Impey S, Ratan RR, Ferrante RJ. 2005. Antioxidants modulate mitochondrial PKA and increase CREB binding to D-loop DNA of the mitochondrial genome in neurons. Proc Natl Acad Sci U S A 102:13915-13920.
73. Sansome C, Zaika A, Marchenko ND, Moll UM. 2001. Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells. FEBS Lett 488:110-115.
74. Saraste M. 1999. Oxidative phosphorylation at the fin de siecle. Science 283:1488-1493.
75. Sawa A, Wiegand GW, Cooper J, Margolis RL, Sharp AH, Lawler JF Jr, Greenamyre JT, Snyder SH, Ross CA. 1999. Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med 5:1194-1198.
76. Schatz G. 1996. The protein import system of mitochondria. J Biol Chem 271:31763-31766.
77. Schiefer J, Landwehrmeyer GB, Luesse HG, Sprunken A, Puls C, Milkereit A, Milkereit E, Kosinski CM. 2002. Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease. Mov Disord 17:748-757.
78. Schultz TW, Sinks GD, Cronin MT. 2002. Structure-activity relationships for gene activation oestrogenicity: evaluation of a diverse set of aromatic chemicals. Environ Toxicol 17:14-23.
79. Shadel GS, Clayton DA. 1997. Mitochondrial DNA maintenance in vertebrates. Annu Rev Biochem 66:409-435.
80. Smith AG, Muscat GE. 2005. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease. Int J Biochem Cell Biol 37:2047-2063.
81. Sterling K, Milch PO, Brenner MA, Lazarus JH. 1977. Thyroid hormone action: the mitochondrial pathway. Science 197:996-999.
82. Stroppolo A, Tian C, Guinea B, Olm V, Sheffield R, Sommer J, Ehrlich ME. 2004. 17Beta-estradiol promotes striatal medium size spiny neuronal maturation in vitro. Neuroendocrinology 79:259-267.
83. Taanman JW. 1999. The mitochondrial genome: structure, transcription, translation and replication. Biochim Biophys Acta 1410:103-123.
84. Tergaonkar V, Pando M, Vafa O, Wahl G, Verma I. 2002. p53 Stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy. Cancer Cell 1:493-503.
85. Tomita Y, Marchenko N, Erster S, Nemajerova A, Dehner A, Klein C, Pan H, Kessler H, Pancoska P, Moll UM. 2006. WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J Biol Chem 281:8600-8606.
86. Valverde JR, Marco R, Garesse R. 1994. A conserved heptamer motif for ribosomal RNA transcription termination in animal mitochondria. Proc Natl Acad Sci U S A 91:5368-5371.
87. Wallace DC. 1999. Mitochondrial diseases in man and mouse. Science 283:1482-1488.
88. Weaver CE Jr, Park-Chung M, Gibbs TT, Farb DH. 1997. 17Beta-estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res 761:338-341.
89. Wilson BE, Mochon E, Boxer LM. 1996. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol Cell Biol 16:5546-5556.
90. Woronicz JD, Calnan B, Ngo V, Winoto A. 1994. Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 367:277-281.
91. Wrutniak C, Cassar-Malek I, Marchai S, Rascle A, Heusser S, Keller JM, Flechon J, Dauca M, Samarut J, Ghysdael J, et al. 1995. A 43-kDa protein related to c-Erb A alpha 1 is located in the mitochondrial matrix of rat liver. J Biol Chem 270:16347-16354.
92. Wrutniak-Cabello C, Casas F, Cabello G. 2001. Thyroid hormone action in mitochondria. J Mol Endocrinol 26:67-77.
93. Xue B, Hay M. 2003. 17Beta-estradiol inhibits excitatory amino acid-induced activity of neurons of the nucleus tractus solitarius. Brain Res 976:41-52.
94. Yager JD, Chen JQ. 2007. Mitochondrial estrogen receptors - new insights into specific functions. Trends Endocrinol Metab 18:89-91.
95. Yang SH, Liu R, Perez EJ, Wen Y, Stevens SM Jr, Valencia T, Brun-Zinkernagel AM, Prokai L, Will Y, Dykens J, Koulen P, Simpkins JW. 2004. Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci U S A 101:4130-4135.
96. Yu X, Rajala RV, McGinnis JF, Li F, Anderson RE, Yan X, Li S, Elias RV, Knapp RR, Zhou X, Cao W. 2004. Involvement of insulin/phosphoinositide 3-kinase/Akt signal pathway in 17 beta-estradiol-mediated neuroprotection. J Biol Chem 279:13086-13094.
97. Zamzami N, Kroemer G. 2001. The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2:67-71.
98. Zeron MM, Chen N, Moshaver A, Lee AT, Wellington CL, Hayden MR, Raymond LA. 2001. Mutant huntingtin enhances excitotoxic cell death. Mol Cell Neurosci 17:41-53.